Liposomal C6 Ceramide Activates Protein Phosphatase 1 to Inhibit Melanoma Cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liposomal C6 Ceramide Activates Protein Phosphatase 1 to Inhibit Melanoma Cells
Authors
Keywords
Melanoma cells, Apoptosis, Melanocytes, Phosphatases, MTT assay, Melanomas, Cytotoxicity, Cell signaling
Journal
PLoS One
Volume 11, Issue 9, Pages e0159849
Publisher
Public Library of Science (PLoS)
Online
2016-09-16
DOI
10.1371/journal.pone.0159849
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DNA-PKcs interference sensitizes colorectal cancer cells to a mTOR kinase inhibitor WAY-600
- (2015) Ling Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Liposomal short-chain C6 ceramide induces potent anti-osteosarcoma activity in vitro and in vivo
- (2015) Lei Zhai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Preclinical development of a C6-ceramide NanoLiposome, a novel sphingolipid therapeutic
- (2015) Mark Kester et al. BIOLOGICAL CHEMISTRY
- C6 ceramide dramatically increases vincristine sensitivity bothin vivoandin vitro, involving AMP-activated protein kinase–p53 signaling
- (2015) Min-Bin Chen et al. CARCINOGENESIS
- C6 ceramide dramatically enhances docetaxel-induced growth inhibition and apoptosis in cultured breast cancer cells: A mechanism study
- (2015) Lan Yang et al. EXPERIMENTAL CELL RESEARCH
- C6-ceramide nanoliposome suppresses tumor metastasis by eliciting PI3K and PKCζ tumor-suppressive activities and regulating integrin affinity modulation
- (2015) Pu Zhang et al. Scientific Reports
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The role of antigen specificity in the binding of murine monoclonal anti-DNA antibodies to microparticles from apoptotic cells
- (2014) Anirudh J. Ullal et al. CLINICAL IMMUNOLOGY
- Role of Protein Phosphatase 1 in Dephosphorylation of Ebola Virus VP30 Protein and Its Targeting for the Inhibition of Viral Transcription
- (2014) Philipp A. Ilinykh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Smart therapeutic strategies in immuno-oncology
- (2014) Alexander M. M. Eggermont et al. Nature Reviews Clinical Oncology
- Less is as good as more in refractory melanoma
- (2014) Lisa Hutchinson Nature Reviews Clinical Oncology
- Golden age of melanoma therapy
- (2014) Lisa Hutchinson Nature Reviews Clinical Oncology
- Melanoma—the run of success continues
- (2014) Dirk Schadendorf et al. Nature Reviews Clinical Oncology
- A new weapon against metastatic melanoma
- (2014) Katie Kingwell NATURE REVIEWS DRUG DISCOVERY
- The malignant melanoma landscape
- (2014) Rachel M. Webster et al. NATURE REVIEWS DRUG DISCOVERY
- Synergistic combination therapy with nanoliposomal C6-ceramide and vinblastine is associated with autophagy dysfunction in hepatocarcinoma and colorectal cancer models
- (2013) Pavan P. Adiseshaiah et al. CANCER LETTERS
- Activation of AMP-activated protein kinase (AMPK) mediates plumbagin-induced apoptosis and growth inhibition in cultured human colon cancer cells
- (2013) Min-Bin Chen et al. CELLULAR SIGNALLING
- AMP-activated protein kinase (AMPK)/Ulk1-dependent autophagic pathway contributes to C6 ceramide-induced cytotoxic effects in cultured colorectal cancer HT-29 cells
- (2013) Hai-zhong Huo et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Why is melanoma so metastatic?
- (2013) Russell R. Braeuer et al. Pigment Cell & Melanoma Research
- C6-Ceramide Nanoliposomes Target the Warburg Effect in Chronic Lymphocytic Leukemia
- (2013) Lindsay K. Ryland et al. PLoS One
- Ceramide and Apoptosis: Exploring the Enigmatic Connections between Sphingolipid Metabolism and Programmed Cell Death
- (2012) Thomas D. Mullen et al. Anti-Cancer Agents in Medicinal Chemistry
- Insights into melanoma: targeting the mTOR pathway for therapeutics
- (2012) Helena Pópulo et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Co-administration phenoxodiol with doxorubicin synergistically inhibit the activity of sphingosine kinase-1 (SphK1), a potential oncogene of osteosarcoma, to suppress osteosarcoma cell growth both in vivo and in vitro
- (2012) Chen Yao et al. Molecular Oncology
- Co-administration of perifosine with paclitaxel synergistically induces apoptosis in ovarian cancer cells: More than just AKT inhibition
- (2011) Hui Sun et al. CANCER LETTERS
- Ceramide in Chemotherapy of Tumors
- (2011) Marie-Therese Dimanche-Boitrel et al. Recent Patents on Anti-Cancer Drug Discovery
- C6 ceramide potentiates curcumin-induced cell death and apoptosis in melanoma cell lines in vitro
- (2010) Teng Yu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Nanoliposomal ceramide prevents in vivo growth of hepatocellular carcinoma
- (2010) H. R. S. Tagaram et al. GUT
- Exogenous cell-permeable C6 ceramide sensitizes multiple cancer cell lines to Doxorubicin-induced apoptosis by promoting AMPK activation and mTORC1 inhibition
- (2010) C Ji et al. ONCOGENE
- Combining Nanoliposomal Ceramide with Sorafenib Synergistically Inhibits Melanoma and Breast Cancer Cell Survival to Decrease Tumor Development
- (2008) M. A. Tran et al. CLINICAL CANCER RESEARCH
- Rapid Distribution of Liposomal Short-Chain Ceramide in Vitro and in Vivo
- (2008) B. S. Zolnik et al. DRUG METABOLISM AND DISPOSITION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search